nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—melanoma	0.796	1	CbGaD
Neostigmine—Paralysis—Vemurafenib—melanoma	0.0059	0.0434	CcSEcCtD
Neostigmine—Abnormal behaviour—Temozolomide—melanoma	0.00562	0.0414	CcSEcCtD
Neostigmine—Chest tightness—Docetaxel—melanoma	0.00297	0.0219	CcSEcCtD
Neostigmine—Wheezing—Bleomycin—melanoma	0.00241	0.0177	CcSEcCtD
Neostigmine—Lacrimation—Docetaxel—melanoma	0.00237	0.0174	CcSEcCtD
Neostigmine—Urinary incontinence—Carmustine—melanoma	0.00209	0.0154	CcSEcCtD
Neostigmine—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00206	0.0152	CcSEcCtD
Neostigmine—Laryngeal pain—Docetaxel—melanoma	0.00204	0.015	CcSEcCtD
Neostigmine—Urinary incontinence—Temozolomide—melanoma	0.00202	0.0149	CcSEcCtD
Neostigmine—Connective tissue disorder—Vemurafenib—melanoma	0.00202	0.0149	CcSEcCtD
Neostigmine—Coma—Carmustine—melanoma	0.00198	0.0146	CcSEcCtD
Neostigmine—Mediastinal disorder—Vemurafenib—melanoma	0.00185	0.0137	CcSEcCtD
Neostigmine—Chest discomfort—Docetaxel—melanoma	0.00157	0.0116	CcSEcCtD
Neostigmine—Bronchospasm—Bleomycin—melanoma	0.00153	0.0113	CcSEcCtD
Neostigmine—Arthralgia—Vemurafenib—melanoma	0.00152	0.0112	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00151	0.0111	CcSEcCtD
Neostigmine—Lacrimation increased—Docetaxel—melanoma	0.00151	0.0111	CcSEcCtD
Neostigmine—Anaphylactic shock—Vemurafenib—melanoma	0.00146	0.0108	CcSEcCtD
Neostigmine—Nervous system disorder—Vemurafenib—melanoma	0.00143	0.0106	CcSEcCtD
Neostigmine—Skin disorder—Vemurafenib—melanoma	0.00142	0.0105	CcSEcCtD
Neostigmine—Hypotension—Vemurafenib—melanoma	0.00137	0.0101	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00133	0.0098	CcSEcCtD
Neostigmine—Sweating increased—Temozolomide—melanoma	0.00128	0.00942	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00126	0.00929	CcSEcCtD
Neostigmine—Pollakiuria—Temozolomide—melanoma	0.00121	0.00893	CcSEcCtD
Neostigmine—Flushing—Bleomycin—melanoma	0.00116	0.00852	CcSEcCtD
Neostigmine—Flushing—Dactinomycin—melanoma	0.00108	0.00794	CcSEcCtD
Neostigmine—Hypersensitivity—Vemurafenib—melanoma	0.00108	0.00793	CcSEcCtD
Neostigmine—Connective tissue disorder—Carmustine—melanoma	0.00107	0.00787	CcSEcCtD
Neostigmine—Asthenia—Vemurafenib—melanoma	0.00105	0.00772	CcSEcCtD
Neostigmine—Urinary tract disorder—Temozolomide—melanoma	0.00104	0.00765	CcSEcCtD
Neostigmine—Pruritus—Vemurafenib—melanoma	0.00103	0.00761	CcSEcCtD
Neostigmine—Connective tissue disorder—Temozolomide—melanoma	0.00103	0.00761	CcSEcCtD
Neostigmine—Urethral disorder—Temozolomide—melanoma	0.00103	0.00759	CcSEcCtD
Neostigmine—Flushing—Carmustine—melanoma	0.00101	0.00743	CcSEcCtD
Neostigmine—Diarrhoea—Vemurafenib—melanoma	0.001	0.00736	CcSEcCtD
Neostigmine—Flushing—Temozolomide—melanoma	0.000976	0.00718	CcSEcCtD
Neostigmine—Arrhythmia—Carmustine—melanoma	0.000972	0.00716	CcSEcCtD
Neostigmine—Dizziness—Vemurafenib—melanoma	0.000967	0.00712	CcSEcCtD
Neostigmine—Mental disorder—Carmustine—melanoma	0.000953	0.00702	CcSEcCtD
Neostigmine—Mediastinal disorder—Temozolomide—melanoma	0.000948	0.00698	CcSEcCtD
Neostigmine—Vomiting—Vemurafenib—melanoma	0.000929	0.00684	CcSEcCtD
Neostigmine—Rash—Vemurafenib—melanoma	0.000922	0.00679	CcSEcCtD
Neostigmine—Mental disorder—Temozolomide—melanoma	0.000921	0.00678	CcSEcCtD
Neostigmine—Dermatitis—Vemurafenib—melanoma	0.000921	0.00678	CcSEcCtD
Neostigmine—Headache—Vemurafenib—melanoma	0.000916	0.00674	CcSEcCtD
Neostigmine—Cramp muscle—Docetaxel—melanoma	0.00091	0.0067	CcSEcCtD
Neostigmine—Anaphylactic shock—Bleomycin—melanoma	0.000886	0.00652	CcSEcCtD
Neostigmine—Agitation—Carmustine—melanoma	0.00087	0.00641	CcSEcCtD
Neostigmine—Nausea—Vemurafenib—melanoma	0.000868	0.00639	CcSEcCtD
Neostigmine—Bronchospasm—Docetaxel—melanoma	0.000859	0.00633	CcSEcCtD
Neostigmine—Agitation—Temozolomide—melanoma	0.000841	0.00619	CcSEcCtD
Neostigmine—Hypotension—Bleomycin—melanoma	0.000828	0.00609	CcSEcCtD
Neostigmine—Convulsion—Carmustine—melanoma	0.000821	0.00604	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000807	0.00594	CcSEcCtD
Neostigmine—Convulsion—Temozolomide—melanoma	0.000793	0.00584	CcSEcCtD
Neostigmine—Dyspnoea—Bleomycin—melanoma	0.00079	0.00581	CcSEcCtD
Neostigmine—Arthralgia—Temozolomide—melanoma	0.000779	0.00574	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000774	0.0057	CcSEcCtD
Neostigmine—Dry mouth—Temozolomide—melanoma	0.000762	0.00561	CcSEcCtD
Neostigmine—Tachycardia—Carmustine—melanoma	0.000754	0.00555	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000753	0.00554	CcSEcCtD
Neostigmine—Anaphylactic shock—Temozolomide—melanoma	0.000747	0.0055	CcSEcCtD
Neostigmine—Nervous system disorder—Temozolomide—melanoma	0.000733	0.00539	CcSEcCtD
Neostigmine—Skin disorder—Temozolomide—melanoma	0.000726	0.00534	CcSEcCtD
Neostigmine—Hypotension—Carmustine—melanoma	0.000722	0.00532	CcSEcCtD
Neostigmine—Hyperhidrosis—Temozolomide—melanoma	0.000722	0.00532	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Carmustine—melanoma	0.000704	0.00519	CcSEcCtD
Neostigmine—Urticaria—Bleomycin—melanoma	0.000704	0.00518	CcSEcCtD
Neostigmine—Insomnia—Carmustine—melanoma	0.000699	0.00515	CcSEcCtD
Neostigmine—Urinary tract disorder—Docetaxel—melanoma	0.000691	0.00508	CcSEcCtD
Neostigmine—Dyspnoea—Carmustine—melanoma	0.000689	0.00507	CcSEcCtD
Neostigmine—Somnolence—Carmustine—melanoma	0.000687	0.00506	CcSEcCtD
Neostigmine—Connective tissue disorder—Docetaxel—melanoma	0.000687	0.00506	CcSEcCtD
Neostigmine—Urethral disorder—Docetaxel—melanoma	0.000685	0.00505	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000681	0.00501	CcSEcCtD
Neostigmine—Insomnia—Temozolomide—melanoma	0.000676	0.00497	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—melanoma	0.000675	0.00497	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Carmustine—melanoma	0.000667	0.00491	CcSEcCtD
Neostigmine—Dyspnoea—Temozolomide—melanoma	0.000666	0.0049	CcSEcCtD
Neostigmine—Somnolence—Temozolomide—melanoma	0.000664	0.00489	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—melanoma	0.000653	0.00481	CcSEcCtD
Neostigmine—Hypersensitivity—Bleomycin—melanoma	0.000652	0.0048	CcSEcCtD
Neostigmine—Flushing—Docetaxel—melanoma	0.000649	0.00478	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Temozolomide—melanoma	0.000645	0.00475	CcSEcCtD
Neostigmine—Asthenia—Bleomycin—melanoma	0.000635	0.00468	CcSEcCtD
Neostigmine—Gastrointestinal pain—Carmustine—melanoma	0.000632	0.00465	CcSEcCtD
Neostigmine—Mediastinal disorder—Docetaxel—melanoma	0.00063	0.00464	CcSEcCtD
Neostigmine—Pruritus—Bleomycin—melanoma	0.000627	0.00461	CcSEcCtD
Neostigmine—Arrhythmia—Docetaxel—melanoma	0.000625	0.0046	CcSEcCtD
Neostigmine—Mental disorder—Docetaxel—melanoma	0.000613	0.00451	CcSEcCtD
Neostigmine—Abdominal pain—Carmustine—melanoma	0.000611	0.0045	CcSEcCtD
Neostigmine—Gastrointestinal pain—Temozolomide—melanoma	0.000611	0.0045	CcSEcCtD
Neostigmine—Hypersensitivity—Dactinomycin—melanoma	0.000609	0.00448	CcSEcCtD
Neostigmine—Urticaria—Temozolomide—melanoma	0.000593	0.00437	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—melanoma	0.000593	0.00436	CcSEcCtD
Neostigmine—Abdominal pain—Temozolomide—melanoma	0.000591	0.00435	CcSEcCtD
Neostigmine—Muscle spasms—Docetaxel—melanoma	0.000585	0.00431	CcSEcCtD
Neostigmine—Hypersensitivity—Carmustine—melanoma	0.00057	0.00419	CcSEcCtD
Neostigmine—Diarrhoea—Dactinomycin—melanoma	0.000565	0.00416	CcSEcCtD
Neostigmine—Vomiting—Bleomycin—melanoma	0.000563	0.00415	CcSEcCtD
Neostigmine—Rash—Bleomycin—melanoma	0.000558	0.00411	CcSEcCtD
Neostigmine—Dermatitis—Bleomycin—melanoma	0.000558	0.00411	CcSEcCtD
Neostigmine—Asthenia—Carmustine—melanoma	0.000555	0.00408	CcSEcCtD
Neostigmine—Hypersensitivity—Temozolomide—melanoma	0.00055	0.00405	CcSEcCtD
Neostigmine—Syncope—Docetaxel—melanoma	0.000546	0.00402	CcSEcCtD
Neostigmine—Asthenia—Temozolomide—melanoma	0.000536	0.00395	CcSEcCtD
Neostigmine—Loss of consciousness—Docetaxel—melanoma	0.000535	0.00394	CcSEcCtD
Neostigmine—Diarrhoea—Carmustine—melanoma	0.000529	0.00389	CcSEcCtD
Neostigmine—Pruritus—Temozolomide—melanoma	0.000529	0.00389	CcSEcCtD
Neostigmine—Convulsion—Docetaxel—melanoma	0.000527	0.00388	CcSEcCtD
Neostigmine—Nausea—Bleomycin—melanoma	0.000526	0.00387	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—melanoma	0.000525	0.00387	CcSEcCtD
Neostigmine—Rash—Dactinomycin—melanoma	0.000521	0.00383	CcSEcCtD
Neostigmine—Arthralgia—Docetaxel—melanoma	0.000518	0.00382	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000515	0.00379	CcSEcCtD
Neostigmine—Dizziness—Carmustine—melanoma	0.000511	0.00376	CcSEcCtD
Neostigmine—Diarrhoea—Temozolomide—melanoma	0.000511	0.00376	CcSEcCtD
Neostigmine—Dry mouth—Docetaxel—melanoma	0.000507	0.00373	CcSEcCtD
Neostigmine—Anaphylactic shock—Docetaxel—melanoma	0.000497	0.00366	CcSEcCtD
Neostigmine—Dizziness—Temozolomide—melanoma	0.000494	0.00364	CcSEcCtD
Neostigmine—Vomiting—Carmustine—melanoma	0.000492	0.00362	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—melanoma	0.000491	0.00361	CcSEcCtD
Neostigmine—Shock—Docetaxel—melanoma	0.000489	0.0036	CcSEcCtD
Neostigmine—Rash—Carmustine—melanoma	0.000487	0.00359	CcSEcCtD
Neostigmine—Nervous system disorder—Docetaxel—melanoma	0.000487	0.00359	CcSEcCtD
Neostigmine—Dermatitis—Carmustine—melanoma	0.000487	0.00359	CcSEcCtD
Neostigmine—Tachycardia—Docetaxel—melanoma	0.000485	0.00357	CcSEcCtD
Neostigmine—Headache—Carmustine—melanoma	0.000484	0.00357	CcSEcCtD
Neostigmine—Skin disorder—Docetaxel—melanoma	0.000483	0.00355	CcSEcCtD
Neostigmine—Vomiting—Temozolomide—melanoma	0.000475	0.0035	CcSEcCtD
Neostigmine—Rash—Temozolomide—melanoma	0.000471	0.00347	CcSEcCtD
Neostigmine—Dermatitis—Temozolomide—melanoma	0.000471	0.00346	CcSEcCtD
Neostigmine—Headache—Temozolomide—melanoma	0.000468	0.00345	CcSEcCtD
Neostigmine—Hypotension—Docetaxel—melanoma	0.000464	0.00342	CcSEcCtD
Neostigmine—Nausea—Carmustine—melanoma	0.000459	0.00338	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000453	0.00333	CcSEcCtD
Neostigmine—Insomnia—Docetaxel—melanoma	0.000449	0.00331	CcSEcCtD
Neostigmine—Nausea—Temozolomide—melanoma	0.000444	0.00327	CcSEcCtD
Neostigmine—Dyspnoea—Docetaxel—melanoma	0.000443	0.00326	CcSEcCtD
Neostigmine—Somnolence—Docetaxel—melanoma	0.000442	0.00325	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Docetaxel—melanoma	0.000429	0.00316	CcSEcCtD
Neostigmine—Gastrointestinal pain—Docetaxel—melanoma	0.000406	0.00299	CcSEcCtD
Neostigmine—Abdominal pain—Docetaxel—melanoma	0.000393	0.00289	CcSEcCtD
Neostigmine—Hypersensitivity—Docetaxel—melanoma	0.000366	0.00269	CcSEcCtD
Neostigmine—Asthenia—Docetaxel—melanoma	0.000356	0.00262	CcSEcCtD
Neostigmine—Pruritus—Docetaxel—melanoma	0.000351	0.00259	CcSEcCtD
Neostigmine—Diarrhoea—Docetaxel—melanoma	0.00034	0.0025	CcSEcCtD
Neostigmine—Dizziness—Docetaxel—melanoma	0.000329	0.00242	CcSEcCtD
Neostigmine—Vomiting—Docetaxel—melanoma	0.000316	0.00233	CcSEcCtD
Neostigmine—Rash—Docetaxel—melanoma	0.000313	0.00231	CcSEcCtD
Neostigmine—Dermatitis—Docetaxel—melanoma	0.000313	0.0023	CcSEcCtD
Neostigmine—Headache—Docetaxel—melanoma	0.000311	0.00229	CcSEcCtD
Neostigmine—Nausea—Docetaxel—melanoma	0.000295	0.00217	CcSEcCtD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CD—melanoma	0.000147	0.00216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS3—melanoma	0.000147	0.00215	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000145	0.00212	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—UGT2B10—melanoma	0.000144	0.00211	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CB—melanoma	0.000144	0.00211	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000143	0.0021	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000142	0.00209	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	0.000139	0.00203	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—PRKCA—melanoma	0.000137	0.002	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000135	0.00197	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	0.000135	0.00197	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HS3ST5—melanoma	0.000134	0.00196	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000133	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—BRAF—melanoma	0.000131	0.00192	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CB—melanoma	0.000128	0.00188	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000128	0.00188	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CD80—melanoma	0.000128	0.00187	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PTEN—melanoma	0.000124	0.00182	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000122	0.00178	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—PRKCA—melanoma	0.000122	0.00178	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000121	0.00177	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP8—melanoma	0.000119	0.00174	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	0.000117	0.00171	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000116	0.00169	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000114	0.00167	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLCB4—melanoma	0.000114	0.00167	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000114	0.00167	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000112	0.00165	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000112	0.00164	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PTEN—melanoma	0.000111	0.00162	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00011	0.00161	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MDM2—melanoma	0.00011	0.00161	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00011	0.00161	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000108	0.00158	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC6A11—melanoma	0.000107	0.00157	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIP4K2A—melanoma	0.000107	0.00157	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—PAX6—melanoma	0.000105	0.00154	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTAP—melanoma	0.000104	0.00153	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000104	0.00152	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	0.000103	0.00151	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000102	0.00149	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000102	0.00149	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLCB4—melanoma	0.000102	0.00149	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IFNG—melanoma	0.000101	0.00148	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—HSPA5—melanoma	0.000101	0.00148	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BRAF—melanoma	0.000101	0.00147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	9.98e-05	0.00146	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	9.96e-05	0.00146	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	9.93e-05	0.00145	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	9.84e-05	0.00144	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	9.81e-05	0.00144	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	9.61e-05	0.00141	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	9.59e-05	0.0014	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIP4K2A—melanoma	9.56e-05	0.0014	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC6A11—melanoma	9.56e-05	0.0014	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	9.54e-05	0.0014	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CXCL8—melanoma	9.41e-05	0.00138	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—PAX6—melanoma	9.38e-05	0.00137	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTAP—melanoma	9.3e-05	0.00136	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LUM—melanoma	9.29e-05	0.00136	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PHGDH—melanoma	9.29e-05	0.00136	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HPSE—melanoma	9.11e-05	0.00133	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	9.09e-05	0.00133	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPA5—melanoma	9.01e-05	0.00132	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP3—melanoma	9e-05	0.00132	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—melanoma	8.99e-05	0.00132	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—melanoma	8.97e-05	0.00131	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	8.95e-05	0.00131	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CUBN—melanoma	8.94e-05	0.00131	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	8.82e-05	0.00129	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—melanoma	8.77e-05	0.00128	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.66e-05	0.00127	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SDHD—melanoma	8.64e-05	0.00126	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CSPG4—melanoma	8.64e-05	0.00126	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BSG—melanoma	8.64e-05	0.00126	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MDM2—melanoma	8.42e-05	0.00123	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	8.39e-05	0.00123	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GPAM—melanoma	8.36e-05	0.00122	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LUM—melanoma	8.29e-05	0.00121	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PHGDH—melanoma	8.29e-05	0.00121	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	8.21e-05	0.0012	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.19e-05	0.0012	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	8.13e-05	0.00119	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HPSE—melanoma	8.13e-05	0.00119	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	8.05e-05	0.00118	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CUBN—melanoma	7.98e-05	0.00117	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.97e-05	0.00117	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	7.89e-05	0.00116	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—melanoma	7.83e-05	0.00115	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.8e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.79e-05	0.00114	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	7.75e-05	0.00113	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SDHD—melanoma	7.7e-05	0.00113	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—BSG—melanoma	7.7e-05	0.00113	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CSPG4—melanoma	7.7e-05	0.00113	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACER3—melanoma	7.7e-05	0.00113	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—melanoma	7.64e-05	0.00112	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	7.61e-05	0.00111	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MDM2—melanoma	7.51e-05	0.0011	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MAPK1—melanoma	7.51e-05	0.0011	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GPAM—melanoma	7.46e-05	0.00109	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	7.46e-05	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.42e-05	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.36e-05	0.00108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLA2G6—melanoma	7.11e-05	0.00104	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	7.09e-05	0.00104	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UGT2B10—melanoma	7.04e-05	0.00103	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.76e-05	0.00099	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	6.72e-05	0.000985	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	6.7e-05	0.000981	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	6.7e-05	0.00098	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—melanoma	6.55e-05	0.000958	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HS3ST5—melanoma	6.55e-05	0.000958	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.54e-05	0.000958	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—VCAN—melanoma	6.39e-05	0.000935	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLA2G6—melanoma	6.34e-05	0.000929	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	6.3e-05	0.000923	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	6.23e-05	0.000912	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.05e-05	0.000885	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—melanoma	6.03e-05	0.000883	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP1—melanoma	5.98e-05	0.000876	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	5.87e-05	0.000859	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.84e-05	0.000854	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	5.77e-05	0.000845	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MAPK1—melanoma	5.76e-05	0.000843	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—VCAN—melanoma	5.7e-05	0.000834	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	5.63e-05	0.000824	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.58e-05	0.000817	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.53e-05	0.000809	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.39e-05	0.00079	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP17A1—melanoma	5.39e-05	0.000789	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	5.38e-05	0.000788	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP1—melanoma	5.34e-05	0.000781	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.32e-05	0.000778	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.31e-05	0.000777	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—melanoma	5.25e-05	0.000768	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.21e-05	0.000762	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MAPK1—melanoma	5.14e-05	0.000752	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNA11—melanoma	5.09e-05	0.000745	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.04e-05	0.000738	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FASN—melanoma	4.98e-05	0.000729	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	4.96e-05	0.000727	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLCB4—melanoma	4.96e-05	0.000726	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A5—melanoma	4.9e-05	0.000717	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.89e-05	0.000717	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP17A1—melanoma	4.81e-05	0.000704	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	4.79e-05	0.000701	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF1—melanoma	4.78e-05	0.0007	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.74e-05	0.000694	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CD44—melanoma	4.73e-05	0.000693	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNAQ—melanoma	4.73e-05	0.000693	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	4.68e-05	0.000685	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC6A11—melanoma	4.66e-05	0.000683	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIP4K2A—melanoma	4.66e-05	0.000683	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.63e-05	0.000678	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—melanoma	4.63e-05	0.000678	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—melanoma	4.62e-05	0.000677	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.59e-05	0.000672	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.55e-05	0.000667	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNA11—melanoma	4.54e-05	0.000665	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1B1—melanoma	4.54e-05	0.000664	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTAP—melanoma	4.54e-05	0.000664	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.53e-05	0.000664	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FASN—melanoma	4.44e-05	0.000651	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.44e-05	0.00065	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A5—melanoma	4.37e-05	0.00064	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.32e-05	0.000633	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.28e-05	0.000627	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF1—melanoma	4.27e-05	0.000625	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNAQ—melanoma	4.22e-05	0.000618	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CD44—melanoma	4.22e-05	0.000618	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.18e-05	0.000612	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.17e-05	0.000611	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.15e-05	0.000608	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.13e-05	0.000605	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—melanoma	4.13e-05	0.000605	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—melanoma	4.12e-05	0.000604	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.1e-05	0.0006	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1B1—melanoma	4.05e-05	0.000593	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LUM—melanoma	4.04e-05	0.000592	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PHGDH—melanoma	4.04e-05	0.000592	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	4e-05	0.000586	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPSE—melanoma	3.97e-05	0.000581	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CUBN—melanoma	3.89e-05	0.00057	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—melanoma	3.85e-05	0.000563	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.77e-05	0.000552	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SDHD—melanoma	3.76e-05	0.00055	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CSPG4—melanoma	3.76e-05	0.00055	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BSG—melanoma	3.76e-05	0.00055	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—melanoma	3.74e-05	0.000547	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPAM—melanoma	3.64e-05	0.000533	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.57e-05	0.000523	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.57e-05	0.000522	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTNNB1—melanoma	3.55e-05	0.00052	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.47e-05	0.000508	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PRKCA—melanoma	3.44e-05	0.000503	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—melanoma	3.43e-05	0.000503	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ERCC2—melanoma	3.41e-05	0.000499	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.39e-05	0.000497	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.39e-05	0.000497	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—melanoma	3.33e-05	0.000488	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.23e-05	0.000473	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.2e-05	0.000469	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTNNB1—melanoma	3.17e-05	0.000464	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLA2G6—melanoma	3.1e-05	0.000453	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PRKCA—melanoma	3.07e-05	0.000449	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ERCC2—melanoma	3.04e-05	0.000445	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.94e-05	0.000431	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.85e-05	0.000417	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.82e-05	0.000414	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—VCAN—melanoma	2.78e-05	0.000407	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—melanoma	2.69e-05	0.000394	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—melanoma	2.6e-05	0.000381	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.52e-05	0.000369	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.41e-05	0.000352	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—melanoma	2.4e-05	0.000352	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—melanoma	2.37e-05	0.000347	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP17A1—melanoma	2.35e-05	0.000343	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—melanoma	2.34e-05	0.000342	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—melanoma	2.32e-05	0.000339	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNA11—melanoma	2.22e-05	0.000324	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.17e-05	0.000318	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FASN—melanoma	2.17e-05	0.000317	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A5—melanoma	2.13e-05	0.000312	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—melanoma	2.11e-05	0.000309	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—melanoma	2.09e-05	0.000305	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—melanoma	2.06e-05	0.000302	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNAQ—melanoma	2.06e-05	0.000302	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CD44—melanoma	2.06e-05	0.000302	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—melanoma	2.04e-05	0.000299	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1B1—melanoma	1.97e-05	0.000289	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—melanoma	1.84e-05	0.00027	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—melanoma	1.82e-05	0.000267	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—melanoma	1.78e-05	0.000261	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—melanoma	1.59e-05	0.000233	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PRKCA—melanoma	1.5e-05	0.000219	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ERCC2—melanoma	1.48e-05	0.000217	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—melanoma	1.26e-05	0.000184	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—melanoma	1.17e-05	0.000172	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—melanoma	1.13e-05	0.000166	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—melanoma	1.12e-05	0.000164	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—melanoma	1.03e-05	0.000151	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—melanoma	1.03e-05	0.00015	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—melanoma	1.02e-05	0.000149	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—melanoma	9.17e-06	0.000134	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—melanoma	8.98e-06	0.000132	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—melanoma	8.9e-06	0.00013	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—melanoma	7.76e-06	0.000114	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—melanoma	5.48e-06	8.02e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—melanoma	4.47e-06	6.55e-05	CbGpPWpGaD
